Novel modified tetanus toxin muscle toning biotherapeutics for:

  • Snoring, Obstructive Sleep Apnoea,

  • Ectropion and other floppy eyelid conditions,

  • cosmetic indications: chin lift, face lift

  • anal incontinence, oesophageal reflux, pelvic floor weakness.

  • neurological muscle disorders such as MS, MND and Myopathy (symptom relief, not a cure)

  • Muscle Rehabilitation and injury recovery.

  • Veterinarian indications: BOAS syndrome, anal incontinence.

Welcome to Snoretox Pty Ltd.

In the laboratories of RMIT University, in Melbourne, Australia, we have invented and patented the world’s first effective and long-lasting muscle toning drug.

Our game-changing technology is based on molecules of tetanus toxin, modified to ensure they work around the tetanus vaccine.

Just as Botox uses tiny amounts of botulinum toxin to relax muscles, our prototype therapeutic uses minute amounts of tetanus toxin to achieve the opposite effect – muscle toning.

Our Aim:

To improve the quality of life for both humans and animals with low tone muscle disorders such as:

  • Sleep apnoea and snoring
  • Cosmetic muscle toning (eyelid issues such as ectropion and ptosis, facial and chin lifting, general muscle toning)
  • Sphincter weakness (anal, oesophageal, bladder, pelvic floor)
  • Neurological (Multiple Sclerosis, Motor Neuron Disease, Myopathy)
  • Veterinary (sleep apnoea, “roaring” larynx disorders, sphincter incontinence, muscle weakness)

Our therapeutics are trademarked SnoretoxTM (for sleep apnoea) and TonetoxTM (for other applications).

Download the detailed Snoretox summary pdf here.